Pharming (PHAR) Return on Invested Capital (2021 - 2026)

Pharming's Return on Invested Capital history runs 6 years deep, the most recent figure standing at 0.0% for Q1 2026.

• Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital was 0.0% for Q1 2026 at Pharming, down from 665.97% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 665.97% in Q4 2025 and bottomed at 0.0% in Q1 2025.
• A 5-year average of 70.17% and a median of 0.0% in 2022 frame the typical range for Return on Invested Capital.
• Peak annual rise in Return on Invested Capital reached 66597 bps in 2025, while the deepest fall reached 18189 bps in 2025.
• Pharming's Return on Invested Capital stood at 0.0% in 2022, then surged by 7128346 bps to 141.08% in 2023, then slumped by 100 bps to 0.0% in 2024, then soared by 21918574 bps to 665.97% in 2025, then slumped by 100 bps to 0.0% in 2026.
• Business Quant data shows PHAR's Return on Invested Capital at 0.0% in Q1 2026, 665.97% in Q4 2025, and 0.0% in Q3 2025.